Medical treatment of heart failure with preserved left ventricular ejection fraction;Tratamiento médico de la insuficiencia cardiaca por disfunción diastólica

Revista Espanola de Cardiologia Suplementos

Volumn 6, Issue F, 2006, Pages

  Anguita Sánchez, Manuel ^a,b   Ojeda Pineda, Soledad ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE   (Spain)

Author keywords

Heart failure; Prognosis; Treatment

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; DIURETIC AGENT; IRBESARTAN; PERINDOPRIL; PLACEBO;

CLINICAL TRIAL; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MORTALITY; PROGNOSIS; REVIEW; SYSTOLIC DYSFUNCTION; CONGESTIVE HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; PATHOPHYSIOLOGY; PHYSIOLOGY;

HEART FAILURE, CONGESTIVE; HUMANS; PROGNOSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 35948972445     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1131-3587(06)74834-8     Document Type: Article

References (29)

1. MacIntyre K, Capewell S, Stewart S, Chalmers JWT, Boyd J, Finlayson A, et al. Evidence of improving prognosis in heart failure. Trends in case fatality I 66547 patients hospitalized between 1986 and 1995. Circulation. 2002;102:1126-31.
2. Rodríguez-Artalejo F, Guallar-Castillón P, Banegas-Banegas JR, Del Rey-Calero J. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. Eur Heart J. 1997;18:1771-9.
3. Senni M, Tribouilly CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community. A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:282-9.
4. Martínez-Sellés M, García-Robles J, Prieto L, Frads E, Muñoz R, Díaz-Castro O, et al. Características de los pacientes ingresados por insuficiencia cardiaca según el estado de su función ventricular. Rev Esp Cardiol. 2002;55:579-86.
5. Ojeda S, Anguita M, Muñoz JF, Rodríguez MT, Mesa D, Franco M, et al. Características clínicas y pronóstico a medio plazo de la insuficiencia cardiaca con función sistólica conservada. Es diferente de la insuficiencia cardiaca sistólica? Rev Esp Cardiol. 2003;56:1050-6.
6. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. Prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948-55.
7. García-Castelao A, Muñiz J, Sesma P, Castro-Beiras A. Utilización de recursos diagnósticos u terapéuticos en pacientes ingresados por insuficiencia cardiaca: influencia del servicio de ingreso (estudio INCARGAL). Rev Esp Cardiol. 2003;56:49-56.
8. Zile MR, Brutsaert DL. New concepts in diastolic function and diastolic heart failure: part I. Diagnosis, prognosis and measurements of diastolic function. Circulation. 2002;105:1387-93.
9. Zile MR, Gaasch WH, Carroll JD. Heart failure with normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001;104:779-82.
10. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J. 1998;19:990-1003.
11. Gandi SK, Powers JC, Nomeir A. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17-20.
12. Vasan RS, Levy D. Defining diastolic heart failure: a call for standarized diagnostic criteria. Circulation. 2000;101:2118-21.
13. Yusuff S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, et al, for the CHARM Investigators and Committees. Lancet. 2003;362:777-81.
14. McDermott MM, Feinglass S, Sy J. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med. 1995;99:629-35.
15. De Lemos JA, McGuire D, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362:262-71.
16. Tschope C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J. 2005;26:2277-84.
17. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, et al. Nt-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart. 2003;89:150-4.
18. Varela-Román A, González-Juanatey JR, Basante P, Trillo R, García-Seara J, Martinez-Sande JL, et al. Clinical characteristics and prognosis of hospitalized inpatients with heart failure and preserved or reduced left ventricular ejection fraction. Heart. 2002;88:249-54.
19. Permanyer-Miralda G, Soriano N, Brotons C, Moral I, Pinar J, Cascant P, et al. Características basales y determinantes de la evolución en pacientes ingresados por insuficiencia cardiaca en un hospital general. Rev Esp Cardiol. 2002;55:571-8.
20. Brogen WC, Hillis LD, Flores ED. The natural history of isolated left ventricular diastolic dysfunction. Am J Med. 1992;92:627-30.
21. Dauterman KW, Massie BM, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J. 1998;135:S310-9.
22. Aurigemma GP, Gaasch WH. Diastolic heart failure. N Engl J Med. 2004;351:1097-105.
23. Martínez-Sellés M, García-Robles JA, Prieto L, Domínguez M, Frades E, Díaz-Castro O, et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J. 2003;24;2046-53.
24. Grigorian Shamagian L, González-Juanatey JR, Varela Román A, García Acuña JM, Virgós Lamela A. The death rate among hospitalizad Herat failure patietns with normal and depressed left ventricular ejection fraction in the year following discharge: evolution over a 10-year period. Eur Heart J. 2005;26:2251-8.
25. The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J. 2005;26:1115-40.
26. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Gamial TG, et al. ACC/AHA 2005 guidelines for the diagnosis and management of chronic heart failure in the adult. Disponible en: www.acc.org/clinical/guidelines/failure/ ind.pdf
27. González-Juanatey JR, Mazón P, Varela A. Insuficiencia cardiaca con función sistólica conservada (insuficiencia cardiaca diastólica). En: Anguita M, editor. Manual de insuficiencia cardiaca. Madrid: Sociedad Española de Cardiología; 2003. p. 91-110.
28. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part II. Causal mechanisms and treatment. Circulation. 2002;105:1503-8.
29. Flather MD, Shibata MC, Coats AJS, Van Veldhuisen DJ, Parkhomenko A, Borbola J et al, on behalf of the SENIORS Investigators. Randomized trial to determine the effect of nevibolol on motality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26:215-25.